Still Foggy, Years After COVID?

Many adults quietly admit their thinking never fully came back. A randomized controlled trial measured this exact population for 60 days — and the group that needed help most responded hardest.

The hardest symptom to explain was the one nobody could see.

You got better. That's what the test said, anyway. The fever passed, you went back to work — and somewhere in the months that followed, you noticed the thing you couldn't quite name: you were still you, just a half-second slower.

If that's familiar, here's the sentence too few people said out loud: you're not imagining it.

"Fine" on paper. Slower in the room where it counts.

"Your labs are normal"

Brain fog became one of the most commonly reported lingering complaints of the post-pandemic years — and one of the least satisfying to seek help for. You describe the slowness, the word-hunting, the fatigue behind the eyes. The bloodwork comes back fine.

Everyone's relieved except you. "Fine" wasn't the question.

So most people did what capable people do: they compensated. More lists. More reminders. More coffee — which sharpened the morning, then billed for it at 3pm. They worked around the fog and called it the new normal.

Here's the problem with "the new normal": it compounds.

The slowness wasn't a character flaw, or aging arrived early. It was a measurable change — which means it could be measured back.

What 70 adults showed researchers

In a 60-day randomized controlled trial, researchers measured exactly this population. Seventy adults, ages 35–65, three groups — assessed with standardized memory and attention tests at Day 0, 30, and 60:

The compounds weren't exotic — citicoline, Alpha-GPC, phosphatidylserine, N-acetyl L-tyrosine, CoQ10, NADH. Substrates the brain uses for neurotransmitter production and cellular energy, studied for decades.

Both formula groups improved. The result that made the study worth publishing: the post-COVID group improved the most.

** Results from a 60-day randomized, placebo-controlled trial (n=70, ages 35–65) measuring standardized memory and attention assessments; figures shown for the Igniton-enhanced post-COVID cohort. Verify all figures against the published PDF linked below. Individual results vary.

Same ingredients. Different results.

A fair reader should be skeptical of supplement studies — most are run by nobody, on nothing, against nothing. The design here is the difference.

The ingredients had been processed through Igniton's patented enhancement. And in the company's foundational 90-day trial (80 adults, Concordia University), the enhanced formula was tested against its own twin — identical molecules, identical doses, without the enhancement. The data, not a theory, makes the comparison:

Relative pattern across the trial's cognitive measures — bar heights illustrative. Exact figures per measure are in the published PDF below.

The enhanced version outperformed on every measure, at every checkpoint.** You don't have to accept any theory about why. The trial was built so the comparison answers instead of the marketing.

And there's a third layer of proof that doesn't require trusting a PDF at all: your own score.

If the fog sounds like yours

The formula from both trials is sold as IgniCognition™ — two capsules each morning. No stimulants, no crash, no cycling. It works alongside coffee rather than replacing it, and the first measurable window in the published research landed at Day 30.

From the research, to the shelf

The trial formula, with the trial's own checkpoint built in

$5.64/day on subscription Baseline quiz Day 0 → retest Day 30.
If your number doesn't move, the refund is yours. No hoops.

See the formula & trial data →

30-day money-back guarantee · Free US shipping on 2+ bottles

The fog arrived without asking. Whether it stays is, at least in part, now a measurable question.